Evelo Biosciences
Latest round
- Series C
Last raised
- Feb 2018
Total raised
- $98M
Investors
- 8
About Evelo Biosciences
Evelo Biosciences, Inc.Founded in 2014 and headquartered in Cambridge, US, Evelo Biosciences, Inc. focuses on therapeutic innovations using its proprietary EDP platform.Evelo Biosciences specializes in developing and commercializing innovative therapeutic treatments that target various medical conditions through its EDP platform. These therapies aim to enhance patient outcomes by addressing inflammatory and autoimmune disorders.Evelo Biosciences generates revenue through direct sales and partnerships within the healthcare sector. It sells its therapies directly to hospitals and clinics, where they are prescribed to patients. Additionally, the company collaborates with pharmaceutical firms to expand its market reach, ensuring a sustainable revenue stream aligned with the value delivered to patients and healthcare systems. The company anticipates expanding its presence in new geographic markets, with specific focus areas yet to be defined. Ongoing clinical trials aim to bring new products to market, further enhancing its therapeutic offerings.
Who invested in Evelo Biosciences
8 investors across 2 rounds
See all investors in Evelo Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Evelo Biosciences
Who invested in Evelo Biosciences?
Evelo Biosciences has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evelo Biosciences raised?
Evelo Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Evelo Biosciences last raise money?
Evelo Biosciences's most recent round on record is a Series C, in Feb 2018.
What does Evelo Biosciences do?
Evelo Biosciences is a biotechnology company.
Where is Evelo Biosciences headquartered?
Evelo Biosciences is headquartered in Cambridge, US.
Which VCs invest in companies like Evelo Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Evelo Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Evelo Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.